Metropolitan Life Insurance Company (MetLife)’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,065	Closed	-$125K	–	2655
2019 Q2	$125K	Hold	9,065	–	–	﹤0.01%	2195
2019 Q1	$156K	Hold	9,065	–	–	﹤0.01%	2063
2018 Q4	$116K	Hold	9,065	–	–	﹤0.01%	2172
2018 Q3	$147K	Buy	+9,065	New	+$130K	﹤0.01%	2208
2014 Q3	–	Sell	-10,762	Closed	-$181K	–	2755
2014 Q2	$181K	Buy	+10,762	New	+$194K	﹤0.01%	2577

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OXFD Position: Q3 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 9,065 shares — an estimated $125K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OXFD in Q2 2014 and held it in 5 quarters. The position peaked at $181K in Q2 2014. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

Metropolitan Life Insurance Company (MetLife) reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 9,065 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $125K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2014 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s Oxford Immunotec Global PLC Ordinary Shares position peaked at $181K in Q2 2014.
73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2019, filed 14 Nov 2019.